NCT05149274

Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

A Randomized, Open-label Study to Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The pharmacokinetics (PK) and safety of oral DWP14012 tablet A will be evaluated and compared with those of DWP14012 tablet B in healthy subjects.

Conditions

• Phase 1 Study, Healthy Volunteers

Interventions

Type	Name	Description
DRUG	DWP14012 Tablet A	DWP14012 10mg
DRUG	DWP14012 Tablet B	DWP14012 40mg

Timeline

• Start date: 2021-10-01
• Primary completion: 2021-10-26
• Completion: 2021-10-26
• First posted: 2021-12-08
• Last updated: 2021-12-08

Locations

1 site across 1 country: South Korea